publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
arch
bronconeumol
w
w
w
r
c
h
b
r
n
c
n
e
u
l
r
g
b
r
c
respiratori
viral
infect
particularli
respiratori
syncyti
viru
rsv
rhinoviru
import
risk
factor
onset
wheez
infant
small
children
bronchiol
common
acut
respiratori
infect
children
year
age
common
caus
hospit
age
group
rsv
account
approxim
case
follow
rhinoviru
adenoviru
metapneumoviru
bocaviru
associ
bronchiol
caus
rsv
develop
recurr
wheez
andor
asthma
first
describ
year
ago
still
unclear
whether
bronchiol
caus
chronic
respiratori
symptom
marker
children
genet
predisposit
develop
asthma
medium
long
term
case
suffici
evid
avail
corrobor
exist
associ
particularli
strong
caus
agent
bronchiol
rhinoviru
pathogen
role
respiratori
virus
trigger
exacerb
asthmat
patient
fulli
character
howev
clear
respiratori
virus
particular
rhinoviru
common
caus
exacerb
children
type
respiratori
viru
identifi
children
hospit
episod
wheez
chang
immun
respons
viral
infect
genet
predispos
individu
like
main
factor
involv
associ
viral
infect
asthma
r
e
u
e
n
la
infeccion
por
viru
respiratorio
especialment
viru
respiratorio
sinciti
vr
rinoviru
suponen
el
mayor
factor
de
riesgo
para
la
de
episodio
de
sibilancia
en
lactant
la
bronquiol
es
la
respiratoria
aguda
de
respiratoria
inferior
en
menor
de
un
constituy
la
causa
frecuent
de
en
est
grupo
de
edad
el
vr
causa
aproximadament
el
de
toda
ella
seguido
por
rinoviru
adenoviru
metapneumoviru
bocaviru
la
entr
bronquiol
por
vr
desarrollo
de
sibilancia
recurrent
yo
asma
ha
sido
descrita
hace
de
aunqu
en
la
actualidad
se
desconoc
con
exactitud
si
la
bronquiol
es
la
causa
de
lo
respiratorio
si
bien
es
un
marcador
que
lo
con
desarrollar
asma
medio
largo
plazo
en
cualquier
caso
exist
evidencia
suficient
como
para
afirmar
que
esta
exist
que
es
especialment
intensa
si
el
agent
asociado
la
bronquiol
es
el
rinoviru
el
papel
de
lo
viru
respiratorio
como
desencadenant
de
exacerbacion
en
el
pacient
totalment
aclarado
pero
sin
duda
lo
viru
respiratorio
en
especi
el
rinoviru
son
el
desencadenant
frecuent
de
exacerbacion
en
lo
llegando
identificars
viru
respiratorio
hasta
en
el
de
lo
hospitalizado
por
un
episodio
de
sibilancia
muy
probablement
la
alteracion
en
la
respuesta
inmun
frent
la
infeccion
viral
en
sujeto
predispuesto
sean
lo
principal
implicado
en
la
virusasma
asthma
chronic
inflammatori
diseas
airway
character
bronchial
hyperrespons
wide
varieti
stimuli
recurr
episod
wheez
respiratori
distress
cough
associ
revers
airway
obstruct
asthma
one
preval
chronic
diseas
worldwid
affect
million
individu
impact
asthma
sever
incid
grow
particularli
develop
countri
respiratori
virus
one
common
caus
asthma
exacerb
adult
children
furthermor
increas
evid
emerg
suggest
viral
respiratori
infect
earli
life
relat
medium
longterm
develop
asthma
articl
aim
first
review
role
virus
precipit
factor
asthma
summar
current
state
knowledg
role
asthma
exacerb
viral
bronchiol
common
featur
clinic
histori
children
go
develop
wheez
asthma
childhood
term
bronchiol
use
sinc
sever
differ
interpret
gener
agreement
definit
review
use
standard
criteria
mcconnochi
describ
bronchiol
first
acut
episod
wheez
preced
respiratori
syndrom
rhinorrhea
cough
tachypnea
occur
without
fever
children
younger
year
age
bronchiol
common
acut
lower
respiratori
tract
infect
children
younger
year
account
pediatr
admiss
respiratori
syncyti
viru
rsv
caus
agent
approxim
case
follow
rhinoviru
adenoviru
human
metapneumoviru
hmpv
human
bocaviru
hbov
common
respiratori
virus
list
tabl
studi
report
global
analys
patient
histori
bronchiol
irrespect
caus
agent
reveal
preval
recurr
wheez
rang
first
year
life
age
year
show
clear
trend
diminish
age
prospect
studi
includ
longterm
followup
children
hospit
bronchiol
irrespect
caus
viru
found
preval
asthma
age
year
patient
histori
bronchiol
compar
rate
control
year
age
preval
signific
impact
healthrel
qualiti
life
data
suggest
recurr
wheez
occur
frequent
children
episod
bronchiol
also
respiratori
symptom
frequent
recur
young
adult
long
symptomfre
period
childhood
adolesc
chang
previous
held
notion
rel
good
prognosi
earli
childhood
wheez
indic
risk
asthma
lung
function
chang
persist
adulthood
rsv
first
viru
associ
develop
asthma
children
although
recent
year
virus
rhinoviru
recent
describ
hmpb
hbov
also
studi
context
rsv
rna
viru
paramyxovirida
famili
often
caus
lower
respiratori
tract
infect
infant
small
children
wittig
glaser
first
describ
epidemiolog
associ
viral
bronchiol
childhood
subsequ
develop
recurr
wheez
andor
asthma
sinc
numer
studi
evalu
relationship
although
differ
methodolog
employ
made
difficult
draw
conclus
definit
prove
associ
howev
recent
sever
prospect
studi
consid
semin
show
histori
bronchiol
caus
rsv
independ
risk
factor
develop
recurr
wheez
medicallydiagnos
asthma
author
sigur
et
al
perform
longest
followup
date
subject
reach
age
year
last
followup
time
point
initi
cohort
consist
infant
age
year
hospit
sever
rsv
bronchiol
ageand
gendermatch
control
children
admit
bronchiol
higher
preval
asthmarecurr
wheez
allerg
sensit
age
year
compar
control
group
age
bronchiol
group
maintain
significantli
higher
preval
asthma
vs
allerg
rhinoconjunct
vs
perenni
allergen
sensit
vs
moreov
age
bronchiol
group
poorer
lung
function
fev
fev
fvc
control
group
irrespect
whether
concomit
asthma
also
preval
bronchial
hyperrespons
bronchodil
respons
final
author
report
risk
factor
independ
relat
diagnosi
asthma
year
age
histori
sever
rsv
bronchiol
presenc
allerg
rhinoconjunct
result
show
sever
rsv
bronchiol
earli
month
life
associ
develop
asthma
bronchial
hyperrespons
allerg
sensit
suggest
associ
continu
adulthood
result
anoth
refer
followup
studi
tucson
children
respiratori
studi
show
rsv
bronchiol
independ
risk
factor
develop
asthma
age
year
associ
disappear
age
differ
longterm
prognosi
may
relat
vari
sever
acut
episod
sinc
sigur
studi
patient
need
hospit
tucson
cohort
includ
mostli
outpati
author
also
observ
greater
risk
asthma
among
children
use
healthcar
resourc
acut
bronchiol
episod
rsv
bronchiol
earli
life
rbel
studi
also
support
associ
sever
rsv
bronchiol
subsequ
develop
asthma
infant
admit
rsv
bronchiol
approxim
diagnos
asthma
age
year
although
rsv
without
doubt
common
viru
etiolog
acut
infantil
bronchiol
use
molecular
diagnost
techniqu
primarili
polymeras
chain
reaction
pcr
establish
respiratori
virus
rhinoviru
also
associ
bronchiol
probabl
develop
asthma
inde
sever
recent
studi
shown
risk
children
hospit
bronchiol
present
asthma
year
higher
among
rsvneg
rsvposit
rhinoviru
rna
viru
picornavirida
famili
first
isol
compris
larg
rna
famili
serotyp
origin
divid
speci
b
recent
addit
c
type
studi
publish
recent
year
suggest
rhinoviru
infect
involv
greater
risk
develop
asthma
rsvassoci
infect
childhood
origin
asthma
coast
studi
follow
cohort
newborn
high
risk
develop
asthma
lower
respiratori
tract
infect
associ
rhinoviru
main
risk
factor
present
recurr
wheez
year
life
odd
ratio
rhinoviru
bronchiol
compar
rsv
bronchiol
moreov
children
rhinovirusassoci
wheez
first
year
life
wors
lung
function
valu
fev
fev
fef
virus
never
present
wheez
midulla
et
al
confirm
role
rhinoviru
bronchiol
one
main
risk
factor
develop
asthma
age
year
coast
studi
also
show
case
rhinoviru
risk
develop
asthma
limit
sever
infect
fact
children
rhinoviru
bronchiol
includ
studi
need
hospit
demonstr
even
mild
rhinoviru
infect
associ
greater
longterm
risk
asthma
final
anoth
cohort
studi
followup
year
show
risk
asthma
adolesc
greater
children
hospit
due
rhinoviru
bronchiol
compar
rsv
bronchiol
studi
also
found
risk
asthma
greater
children
whose
initi
episod
bronchiol
occur
season
winter
predomin
viru
rsv
hmpv
paramyxoviru
discov
identifi
throughout
world
common
caus
acut
respiratori
infect
particularli
infant
small
children
clinic
featur
acut
hmpv
infect
similar
caus
rsv
manifest
mild
upper
respiratori
tract
infect
pneumonia
sever
bronchiol
requir
hospit
admiss
similar
clinic
symptom
rsv
led
specul
hmpv
infect
may
also
associ
develop
asthma
long
term
date
mediumterm
progress
children
admit
hmpv
bronchiol
examin
studi
report
similar
rate
recurr
wheez
seen
children
admit
rsv
bronchiol
rate
control
group
case
hbov
dna
viru
belong
parvovirida
famili
first
identifi
respiratori
sampl
children
lower
respiratori
tract
infect
sinc
numer
studi
investig
preval
role
respiratori
infect
date
examin
possibl
role
develop
asthma
studi
question
report
children
admit
hbov
bronchiol
asthma
age
year
high
rate
hbov
coinfect
respiratori
virus
tendenc
infect
older
children
confound
studi
real
role
earli
hbov
infect
develop
asthma
bronchiolitisasthma
relationship
caus
coincid
discuss
wide
bodi
evid
relat
viral
respiratori
infect
subsequ
develop
asthma
remain
unclear
sever
bronchiol
real
caus
asthma
marker
suscept
identifi
children
predisposit
develop
asthma
prospect
multicent
studi
recent
conduct
europ
unit
state
canada
appear
support
caus
role
rsv
reduct
observ
recurr
wheez
medium
term
among
prematur
babi
famili
histori
asthma
andor
atopi
receiv
prophylaxi
palivizumab
monoclon
antibodi
use
prevent
rsv
infect
curious
protect
effect
observ
children
histori
atopi
suggest
rsv
may
caus
role
pathogenesi
recurr
wheez
patient
genet
predisposit
atopi
possibl
caus
role
viral
bronchiol
question
epidemiolog
studi
perform
monozygot
twin
discord
sever
rsv
bronchiol
infanc
author
found
differ
frequenc
asthma
lung
function
nitric
oxid
level
age
year
twin
sibl
histori
histori
hospit
due
bronchiol
final
anoth
recent
studi
support
hypothesi
earli
viral
infect
marker
atop
predisposit
rather
caus
asthma
one
danish
copenhagen
prospect
studi
asthma
childhood
follow
cohort
newborn
asthmat
mother
investig
measur
lung
function
respons
methacholin
infant
month
life
respiratori
symptom
observ
found
time
point
children
subsequ
develop
sever
bronchiol
alreadi
bronchial
hyperrespons
precursor
bronchiol
result
support
recent
coast
studi
identifi
allerg
sensit
first
year
life
signific
risk
factor
virusassoci
wheez
wheez
associ
respiratori
infect
increas
risk
develop
allerg
sensit
seem
like
hypothes
bronchiol
caus
marker
asthma
mutual
exclus
pathogen
mechan
rhinoviru
rsv
infect
differ
rsv
characterist
produc
cytopath
effect
airway
affect
children
younger
month
frequent
requir
hospit
occur
epidem
outbreak
winter
month
contrast
rhinoviru
outbreak
occur
throughout
year
affect
older
children
gener
treat
outpati
often
famili
histori
asthma
atopi
differ
led
hypothesi
differ
mechan
rhinoviru
bronchiol
may
marker
predisposit
asthma
atopi
rsv
bronchiol
may
greater
caus
role
particularli
sever
case
requir
hospit
role
respiratori
virus
precipit
asthma
attack
adult
children
identifi
year
ago
earli
studi
viral
diagnosi
base
molecular
method
viral
activ
detect
asthma
attack
contrast
recent
year
use
pcr
techniqu
reveal
proport
asthma
exacerb
associ
virus
much
higher
accord
khetsuriani
et
al
accord
johnston
et
al
even
accord
alland
et
al
least
respiratori
viru
identifi
patient
includ
spanish
studi
children
hospit
asthma
exacerb
although
practic
respiratori
virus
includ
newli
identifi
hmpv
hbov
associ
asthma
exacerb
agent
commonli
detect
infant
schoolchildren
rhinoviru
rsv
fact
recent
cohort
studi
infant
suggest
rhinoviru
common
pathogen
first
year
life
import
precipit
wheez
infant
children
school
age
johnston
et
al
found
asthma
exacerb
asthmat
children
age
year
associ
viral
respiratori
infect
two
third
caus
rhinoviru
asthma
exacerb
among
preschooland
schoolag
children
tend
follow
season
pattern
temper
climat
maximum
incid
occur
month
septemb
coincid
begin
school
year
spring
pattern
coincid
almost
exactli
peak
maximum
circul
rhinoviru
commun
suggest
causal
relationship
viru
asthma
exacerb
frequenc
detect
respiratori
virus
adult
asthma
exacerb
rang
accord
result
recent
metaanalysi
although
rhinoviru
also
common
age
group
virus
rsv
hmpv
influenza
viru
appear
play
import
role
asthma
exacerb
adult
clinic
practic
moreov
viral
infect
act
synergi
stimuli
exposur
allergen
allerg
individu
exposur
high
level
environment
contamin
increas
risk
asthma
exacerb
viral
respiratori
infect
affect
lung
mani
way
act
epitheli
cell
antigenpres
cell
recogn
viral
infect
immun
system
stimul
product
cytokin
interleukin
il
thymic
stromal
lymphopoietin
tslp
epitheli
cell
airway
cytokin
induc
immun
respons
airborn
allergen
lung
product
certain
cytokin
cell
subsequ
increas
eosinophil
mast
cell
recruit
caus
inflamm
airway
cell
metaplasia
bronchoconstrict
howev
individu
contract
respiratori
viru
infect
suffer
asthma
exacerb
possibl
certain
risk
factor
increas
suscept
present
wheez
viral
infect
explor
studi
conduct
wark
et
al
contoli
et
al
suggest
absenc
effici
innat
immun
respons
manifest
low
interferon
level
epitheli
cell
asthma
patient
may
assist
viral
replic
lead
exagger
asthmat
respons
seem
highli
like
alter
immun
respons
viral
infect
genet
predispos
subject
major
factor
involv
virusasthma
relationship
